CCSD code K6100 – Single chamber ICD insertion

Key takeaways

CCSD code K6100 covers single chamber ICD insertion only, not dual chamber (K6105), CRT-D, or generator replacement procedures.

Prior authorisation from the patient’s private insurer is mandatory before implantation, and the authorisation reference number must appear on the claim.

The ICD device hardware cost is billed separately from K6100, which covers the surgeon’s procedural fee only.

Count the leads in the operative note before you pick the code, because a second lead moves the claim to K6105.

Pabau’s claims management software keeps the authorisation reference, operative note and invoice in one patient record for UK cardiology teams.

CCSD code K6100: Definition and procedure scope

CCSD code K6100 describes the surgical insertion of a single chamber implantable cardioverter defibrillator. The CCSD schedule defines it as the complete implantation procedure performed by the electrophysiologist, from venous access through to wound closure. The code applies to a de novo implant, where no existing device or lead is in situ.

A single chamber ICD uses one transvenous lead, positioned at the right ventricular apex or septum. The generator sits in a subcutaneous or submuscular pocket, typically below the left clavicle.

The K6100 procedural fee covers the surgeon’s work in that session. That means lead placement, pocket creation, intra-operative defibrillation threshold testing and wound closure.

The code has two scope limits. First, CCSD code K6100 covers the procedural work only. The physical ICD generator and lead hardware are billed separately under device supply codes or negotiated directly with the hospital facility.

Second, K6100 is a de novo code. Generator replacement, lead revision, and device upgrade procedures each have their own CCSD codes and cannot be billed under K6100.

The procedure: What single chamber ICD insertion involves

The operative note that supports a K6100 claim follows the procedure step by step. A single chamber ICD implantation runs in the same sequence whatever the device manufacturer.

1. Venous access: The electrophysiologist gains access to the subclavian or axillary vein using a modified Seldinger technique, under fluoroscopic guidance.
2. Lead advancement: A single defibrillation lead is advanced through the right atrium into the right ventricular apex or high septum. Fluoroscopy and intracardiac electrograms confirm correct positioning and lead stability.
3. Sensing and pacing threshold testing: The lead is tested for sensing amplitude, pacing threshold, and impedance. Values outside acceptable ranges require repositioning before proceeding.
4. Pocket creation: A subcutaneous or submuscular pocket is fashioned below the left clavicle to house the pulse generator.
5. Generator connection and defibrillation threshold testing: The lead is connected to the ICD generator. Defibrillation threshold testing (DFT), where performed, confirms the device can detect and terminate a ventricular arrhythmia. DFT is not performed in every implant, so document it explicitly if it is billed as a separate component.
6. Wound closure: The pocket is closed in layers and the wound is dressed. A post-procedure chest X-ray confirms lead position and excludes pneumothorax.

The operative note must document each of these steps for K6100 to withstand insurer scrutiny. Missing any element, particularly device model and serial number or lead impedance values, is a common trigger for documentation-based denials.

Clinical indications: Who qualifies for K6100?

UK private insurers link prior authorisation for CCSD code K6100 to evidence-based clinical criteria. Most of these mirror NHS England specialised commissioning guidance and NICE technology appraisals on ICD therapy.

Billing teams should be familiar with these indications because the pre-authorisation request must demonstrate clinical justification.

Single chamber ICD implantation is indicated across two categories: primary prevention and secondary prevention.

Primary prevention indications

• Ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) 35% or below, despite optimal medical therapy for at least three months
• Non-ischaemic dilated cardiomyopathy with LVEF 35% or below
• Inherited channelopathies with high-risk features: Brugada syndrome, long QT syndrome, hypertrophic cardiomyopathy with one or more major risk factors
• Arrhythmogenic right ventricular cardiomyopathy (ARVC) with risk stratification criteria met

Secondary prevention indications

• Survivors of cardiac arrest due to ventricular fibrillation (VF) or haemodynamically significant ventricular tachycardia (VT), where reversible causes have been excluded
• Sustained VT causing haemodynamic compromise, in a patient with structural heart disease

The pre-authorisation request should include the relevant echocardiographic report confirming LVEF, the documented arrhythmia history, and the referring cardiologist’s clinical letter confirming the indication. Submitting this evidence upfront reduces the risk of the insurer requesting additional clinical information after the procedure.

What K6100 includes and what it excludes

Unbundling errors and claim disputes on K6100 usually trace back to its scope. The table below sets out what the code covers and what is billed elsewhere.

Always verify the current CCSD schedule year before submission. The CCSD updates its schedule annually, and bundling rules for add-on procedures can change between editions. Check the CCSD technical guide for the applicable schedule year.

K6100 vs related CCSD codes: Choosing the right code

Picking the wrong code within the cardiac device range is a frequent ICD coding error. The table below covers the codes most often confused with CCSD code K6100. For Bupa-specific fees and rules, check our Bupa CCSD codes reference.

The operative note decides which code applies. If it documents a single RV lead placed de novo, K6100 is correct, and any additional lead or a subcutaneous approach changes the code.

Confirm K6105 and its neighbours against the schedule edition in force on the date of procedure, using our CCSD code library. The diagram below maps each lead configuration to its code.

Documentation requirements for K6100 claims

UK private insurers routinely request operative notes for high-value cardiac procedures, and an incomplete note is a straightforward denial trigger. The operative note for a K6100 claim must include all of the following.

• ICD generator details: manufacturer name, device model, and serial number
• Lead details: lead model, serial number, and implant site (e.g. right ventricular apex, high septum)
• Access route: subclavian or axillary vein, technique used (e.g. modified Seldinger)
• Intra-operative measurements: sensing amplitude (R-wave), pacing threshold (voltage and pulse width), and lead impedance at implant
• Defibrillation threshold testing: whether DFT was performed and the result, or documented rationale for omission
• Fluoroscopy use: confirmation that fluoroscopy was used for lead positioning
• Implanting physician details: consultant name, GMC number, and signature
• Procedure date and institution

Supporting documents required at submission typically include:

• The prior authorisation reference number
• The referral letter confirming the indication
• The post-procedure chest X-ray report confirming lead position

Some insurers also require a device implant registration form, particularly Bupa and AXA Health.

A standardised post-procedure checklist in the patient record stops a claim going out with a required field missing.

Prior authorisation: What private payers require before approving K6100

Every major UK private medical insurer requires prior authorisation before an ICD implantation. Without an authorisation reference number, the claim will be denied on submission regardless of how well the procedure is documented. Authorisation must be obtained before the procedure, not after.

The pre-authorisation request to insurers such as Bupa, AXA Health, Aviva, and Vitality typically requires the following clinical evidence.

• Referring cardiologist or electrophysiologist letter confirming the indication (primary or secondary prevention)
• Recent echocardiogram report with documented LVEF for primary prevention cases
• Holter or telemetry records documenting the arrhythmia for secondary prevention cases
• Confirmation that the patient has been on optimised medical therapy for at least three months, where applicable
• Proposed procedure date and treating institution
• The CCSD procedure code (K6100) and the planned device type

Once authorisation is granted, record the reference number in the patient record immediately. The reference number must appear on the invoice submitted to the insurer.

Authorisations are time-limited, typically valid for 90 days, so confirm the procedure date falls within the approved window. An authorisation that has expired is a denial that cannot be appealed on clinical grounds.

Vitality Health provides a fee finder tool at vitality.co.uk/healthcare-providers/fee-finder/ where the applicable K6100 fee can be confirmed before submission. Healix publishes its CCSD fee schedule at hsp.healix.com/hfs, including unbundling guidance relevant to cardiac device codes.

Common reasons K6100 claims are denied and how to avoid them

ICD implantation claims draw close insurer scrutiny because of their value and the number of documentation requirements. The table below covers the most frequent K6100 denial reasons and how to resolve each one.

Automated claim submission checks can flag a missing authorisation number or an incomplete documentation field before the invoice leaves the system. We compare the platforms that run these checks in our roundup of UK medical billing software.

Billing K6100 in practice: A step-by-step claim submission checklist

The checklist below runs from referral to confirmed payment, in the order the billing team meets each task.

Before the procedure

1. Confirm the patient’s private medical insurance policy covers ICD implantation and check whether an excess applies.
2. Submit the pre-authorisation request with full clinical evidence (LVEF report, arrhythmia documentation, cardiologist letter). Record the insurer’s reference number in the patient record.
3. Confirm the procedure date falls within the authorisation validity window (typically 90 days). Note the expiry date.
4. Verify the implanting consultant’s recognition status with the insurer.

At the procedure

1. Confirm the operative note template captures the lead count, lead and generator models and serial numbers, and the access route. It also needs the intra-operative measurements (sensing, threshold, impedance), DFT status, fluoroscopy use and implanting physician details.
2. Record the device serial numbers immediately after implant. Do not rely on memory or post-procedure device registration cards alone.

At claim submission

1. Select CCSD code K6100 and confirm the lead count in the operative note supports a single chamber code (not K6105 or CRT-D).
2. Populate the invoice with the prior authorisation reference number in the designated field.
3. Attach the operative note, post-procedure chest X-ray report, and any insurer-required device registration documentation.
4. Submit via Healthcode or the insurer’s preferred electronic invoicing channel. Healthcode is the dominant EDI platform for UK private medical billing.
5. Check that no bundled components (lead placement, pocket creation) appear as separate line items alongside K6100.

On remittance advice review

1. Reconcile the payment against the submitted fee. Note any shortfall or reduction.
2. Where a denial or reduction arrives, match its reason code to the table above. Then decide whether to appeal or resubmit.
3. Log all denials by reason. Patterns across multiple K6100 claims (e.g. consistent documentation denials from one insurer) signal a process issue to address proactively.

How Pabau keeps K6100 claims clean from referral to remittance

Many cardiology billing teams run this checklist across separate tools. The authorisation reference sits in an email, the operative note in a hospital system, and the invoice in a spreadsheet. Each hand-off is a chance for the serial number or the reference to drop out.

Pabau, the practice management platform we build, holds the patient record, treatment notes and invoices in one place. Its claims management software lets you keep the authorisation reference on the patient record and build an operative note template with every required K6100 field.

The result is a claim that leaves with its evidence attached, so your team spends less time answering insurer queries and resubmitting.

Simplify CCSD claim management for your cardiology practice

Pabau supports UK private practice billing teams with CCSD documentation workflows, claim submission and automated follow-up tools. Your team spends less time chasing payments and more time on patient care.

Book a demo

Conclusion

Count the leads before you pick the code. One transvenous ventricular lead placed de novo is K6100. A second atrial lead, a CRT-D system or a subcutaneous device each moves the claim to another code.

The bigger risk sits outside theatre. An expired authorisation or a note without the device serial number takes far longer to recover than to prevent. Build both checks into the routine before and after every implant, and the claim rarely comes back.

Want the authorisation, operative note and invoice to travel together on every cardiac device claim? Book a demo to see how Pabau handles CCSD billing for private cardiology practices.

Continue your research

Billing coronary procedures as well as device implants? CCSD code K4910 explains coronary angioplasty with stent insertion and its documentation requirements.

Coding cardiac surgery in the same chapter? CCSD code K3210 covers closed mitral valvotomy billing for private cardiac practices.

Choosing a billing system for UK private claims? Best medical billing software in the UK compares the platforms built for insurer and self-pay billing.

Frequently asked questions